Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2074 studies found for:    "Multiple myeloma"
Show Display Options
Rank Status Study
1 Unknown  Stage I Multiple Myeloma Treatment
Condition: Multiple Myeloma
Intervention: Drug: zometa
2 Completed Thalidomide for Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Thalidomide
3 Approved for marketing Carfilzomib Multiple Myeloma Expanded Access Protocol for Patients With Relapsed and Refractory Disease
Condition: Multiple Myeloma
Intervention: Drug: Carfilzomib
4 Active, not recruiting Hemostatic Effects of VELCADE®* Treatment in Multiple Myeloma Patients
Condition: Multiple Myeloma
Intervention: Drug: Velcade
5 Completed Efficacy Study of ZD6474 to Treat Multiple Myeloma Cancer
Condition: Multiple Myeloma
Interventions: Drug: ZD6474;   Drug: VEGF-receptor tyrosine kinase (KDR)
6 Recruiting UARK 2010-35, A Study of Expanded Natural Killer Cell Therapy for Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Bortezomib
7 Terminated A Phase II Study of Clofarabine in Patients With Relapsed or Refractory Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Clofarabine
8 Completed
Has Results
Bortezomib With Melphalan and Prednisone for Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Bortezomib;   Drug: Melphalan;   Drug: Prednisone
9 Active, not recruiting Bendamustine + Pomalidomide + Dex in R/R Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Bendamustine;   Drug: Pomalidomide;   Drug: Dexamethasone
10 Recruiting Treatment of Chemotherapy Refractory Multiple Myeloma by CART-138
Condition: Multiple Myeloma
Intervention: Biological: CART-138 cells
11 Terminated
Has Results
Efficacy and Safety Study of SyB L-0501 for Patients With Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: SyB L-0501;   Drug: prednisolone
12 Completed Safety and Efficacy of Atiprimod for Patients With Refractory Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Atiprimod
13 Completed Pethema Multiple Myeloma 2000
Condition: Multiple Myeloma
Interventions: Drug: Alternating chemotherapy;   Procedure: Autologous Transplantation;   Drug: Maintenance;   Procedure: Second transplantation;   Procedure: ALOGENIC MINI TRASPLANTATION
14 Terminated Autologous Stem Cell Transplantation and Maintenance Therapy for Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Melphalan;   Drug: Lenalidomide
15 Unknown  Study of Fluphenazine in Relapsed or Relapsed-and-Refractory Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Fluphenazine HCl
16 Terminated
Has Results
Study of Velcade® and Bone Formation in Patients With Relapsed/Refractory Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: VELCADE™
17 Completed Protocol of the Combination of Bortezomib and Tipifarnib for Relapsed or Refractory Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Bortezomib and Tipifarnib
18 Completed
Has Results
Celgene High Risk Multiple Myeloma (MM) Revlimid Induction and Maintenance Therapy
Condition: Multiple Myeloma
Interventions: Drug: Lenalidomide Induction;   Drug: Sequential Maintenance Therapy
19 Recruiting Study of Bendamustine and IXAZOMIB (MLN9708) Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: MLN9708;   Drug: Dexamethasone;   Drug: Bendamustine
20 Terminated Trisenox, Ascorbic Acid and Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Arsenic Trioxide, Ascorbic Acid and Bortezomib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.